Scientists share details of successful clinical trial of TCM.

KARACHI -- Successful clinical trial of "Yinhuang Qingfei Capsules," the first traditional Chinese medicine (TCM) ever tested in Pakistan was cited to be a major success for the country's health care system.

"The herb-based Chinese medicine will be an efficient alternative for antibiotics currently recommended for chronic bronchitis," said Prof. Dr. M. Raza Shah, the in-charge of the

clinical trial project in a press conference held here on Saturday.

Sharing details of the exercise, he said to introduce the effective treatment strategies and drugs for patients with chronic bronchitis in Pakistan, clinical confirmatory trials were conducted by the Center for Bioequivalence Studies and Clinical Research (CBSCR), which works as a component of Dr. Panjwani Center for Molecular Medicine and Drug Research, University of Karachi.

The press conference held at the International Center for Chemical and Biological Sciences (ICCBS), University of Karachi was also attended by other medical experts from Pakistan and

China.

Director ICCBS Prof. Dr. M. Iqbal Choudhary and Mr. Guo Chunshui, Commercial Counselor of Consulate General in Karachi, Mr. Jian Zhang, Vice Chairperson of Hunan Provincial Committee of

CPPCC, Chairperson of Hunan Federation of Industry and Commerce, President of Hunan General Chamber of Commerce, and Mr. Feibao Chen, President of Hunan Anbang Pharmaceutical Company were also present on the occasion.

It was mentioned on the occasion that "Yinhuang Qingfei Capsules," was a natural herbs preparation developed by Hunan Anbang Pharmaceutical for the treatment of an acute attack of

chronic bronchitis.

Chronic bronchitis is a common disease related to chronic inflammation, which is caused by a variety of pathogenic factors, such as air pollution, smoking, and pathogen infection, he said.

It was commented that although current treatments such as bronchodilators, antitussive drugs, steroids and leukotriene (LT) receptor antagonists can...